Form 8-K - Current report:
SEC Accession No. 0001104659-23-037397
Filing Date
2023-03-28
Accepted
2023-03-28 07:36:37
Documents
14
Period of Report
2023-03-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310682d1_8k.htm   iXBRL 8-K 25625
2 EXHIBIT 99.1 tm2310682d1_ex99-1.htm EX-99.1 16794
6 GRAPHIC tm2310682d1_ex99-1img001.jpg GRAPHIC 3156
  Complete submission text file 0001104659-23-037397.txt   227182

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20230328.xsd EX-101.SCH 3025
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20230328_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20230328_pre.xml EX-101.PRE 22590
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310682d1_8k_htm.xml XML 3613
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 23766174
SIC: 2836 Biological Products, (No Diagnostic Substances)